MXPA04006210A - Composiciones acuosas que contienen metronidazole. - Google Patents
Composiciones acuosas que contienen metronidazole.Info
- Publication number
- MXPA04006210A MXPA04006210A MXPA04006210A MXPA04006210A MXPA04006210A MX PA04006210 A MXPA04006210 A MX PA04006210A MX PA04006210 A MXPA04006210 A MX PA04006210A MX PA04006210 A MXPA04006210 A MX PA04006210A MX PA04006210 A MXPA04006210 A MX PA04006210A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions containing
- aqueous compositions
- metronidazole
- containing metronidazole
- cyclodextrin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/16—Cyclodextrin; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una solucion acuosa de metronidazole en la - cual la concentracion de metronidazole es mayor al 0.75%. La solucion contiene una combinacion de agentes mejoradores de - solubilidad, uno de los cuales es una ciclodextrina, tal como beta-ciclodextrina y el segundo es un compuesto distinto a la ciclodextrina. Se dan a conocer tambien metodos de elaboracion y uso terapeutico de la solucion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/033,835 US6881726B2 (en) | 2001-12-24 | 2001-12-24 | Aqueous compositions containing metronidazole |
PCT/US2002/036063 WO2003057135A2 (en) | 2001-12-24 | 2002-11-07 | Aqueous compositions containing metronidazole |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04006210A true MXPA04006210A (es) | 2005-05-17 |
Family
ID=21872727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04006210A MXPA04006210A (es) | 2001-12-24 | 2002-11-07 | Composiciones acuosas que contienen metronidazole. |
Country Status (20)
Country | Link |
---|---|
US (4) | US6881726B2 (es) |
EP (3) | EP1467744B1 (es) |
JP (1) | JP4611632B2 (es) |
KR (1) | KR100718858B1 (es) |
CN (1) | CN100411624C (es) |
AR (1) | AR037755A1 (es) |
AT (1) | ATE481105T1 (es) |
AU (1) | AU2002340458B2 (es) |
BR (1) | BRPI0215331B8 (es) |
CA (1) | CA2470492C (es) |
CY (1) | CY1111095T1 (es) |
DE (1) | DE60237710D1 (es) |
DK (1) | DK1467744T3 (es) |
ES (1) | ES2352656T3 (es) |
HK (1) | HK1071514A1 (es) |
MX (1) | MXPA04006210A (es) |
PT (1) | PT1467744E (es) |
RU (2) | RU2284810C2 (es) |
WO (1) | WO2003057135A2 (es) |
ZA (1) | ZA200405059B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6468989B1 (en) * | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
DE10306453A1 (de) * | 2003-02-17 | 2004-08-26 | Deutsche Telekom Ag | Administrator |
US7456207B2 (en) * | 2003-09-25 | 2008-11-25 | Teva Pharmaceuticals Usa, Inc. | Vaginal pharmaceutical compositions and methods for preparing them |
FR2866566A1 (fr) * | 2004-02-20 | 2005-08-26 | Galderma Res & Dev | Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee |
FR2887149B1 (fr) * | 2005-06-17 | 2007-08-03 | Galderma Sa | Procede de solubilisation du metronidazole |
US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
US9446226B2 (en) * | 2005-12-07 | 2016-09-20 | Ramot At Tel-Aviv University Ltd. | Drug-delivering composite structures |
JP2010520897A (ja) * | 2007-03-12 | 2010-06-17 | ディーエスエム アイピー アセッツ ビー.ブイ. | 化粧品組成物 |
US20080287513A1 (en) * | 2007-05-14 | 2008-11-20 | Jerry Zhang | Topical compositions containing metronidazole |
US20080287514A1 (en) * | 2007-05-14 | 2008-11-20 | Jerry Zhang | Topical compositions containing metronidazole |
US20080312304A1 (en) * | 2007-06-13 | 2008-12-18 | Jerry Zhang | Topical compositions containing metronidazole |
WO2009031577A1 (ja) * | 2007-09-04 | 2009-03-12 | Meiji Seika Kaisha, Ltd. | 注射剤、注射液および注射用キット製剤 |
AR061947A1 (es) * | 2008-01-08 | 2008-08-10 | Oscar Belluscio Daniel | Metodo para la obtencion del complejo gonadotrofina corionica humana (gch) / ciclodextrina administrable por via oral, producto obtenido con dicho metodo y uso clinico-terapeutico del complejo gonadotrofina corionica humana (gch) / ciclodextrina |
US7893097B2 (en) * | 2008-02-02 | 2011-02-22 | Dow Pharmaceutical Sciences, Inc. | Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
US20110091515A1 (en) * | 2008-06-12 | 2011-04-21 | Ramot At Tel-Aviv University Ltd. | Drug-eluting medical devices |
US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
WO2010047831A1 (en) * | 2008-10-23 | 2010-04-29 | Nycomed Us Inc. | Stable metronidazole gel formulations |
EP2201930A1 (en) | 2008-12-23 | 2010-06-30 | Intendis GmbH | Hydrogel composition for the treatment of dermatological disorders |
AU2010237599A1 (en) * | 2009-04-14 | 2011-12-08 | Medortus (Uk) Ltd | Gel compositions for administration of pharmaceutically active compounds |
CA2822995C (en) * | 2010-12-31 | 2021-05-11 | Eastpond Laboratories Limited | Cellular hydration compositions containing cyclodextrins |
CN105903028B (zh) * | 2010-12-31 | 2020-10-16 | 东塘实验室有限公司 | 含有环糊精的细胞水合组合物 |
US20120171184A1 (en) | 2010-12-31 | 2012-07-05 | Lajos Szente | Cellular hydration compositions |
CA2825417A1 (en) | 2011-01-25 | 2012-08-02 | The Procter And Gamble Company | Liposome and personal care composition comprising thereof |
BR112013033759B1 (pt) | 2011-06-28 | 2021-05-25 | Chemo Research Sl | forma de dosagem unitária de um gel de base aquosa de metronidazol mucoadesivo e uso relacionado ao gel de base aquosa de metronidazol |
US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
EP2952208A1 (en) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalcoholic system for nail treatment |
JP2015044850A (ja) * | 2014-11-07 | 2015-03-12 | イーストポンド・ラボラトリーズ・リミテッド | シクロデキストリンを含有する細胞水和組成物 |
US9492374B2 (en) * | 2015-03-25 | 2016-11-15 | Jose Rafael Salinas Andrade | Composition and method for treatment of ulcers |
RU2020122841A (ru) | 2017-12-15 | 2022-01-18 | Тарсус Фармасьютикалс, Инк. | Изоксазолиновые паразитицидные составы и способы лечения блефарита |
US11198831B2 (en) | 2019-01-31 | 2021-12-14 | Kvi Llc | Lubricant for a device |
CN111840632A (zh) * | 2019-04-25 | 2020-10-30 | 广东泰宝医疗科技股份有限公司 | 一种含止血微囊的液体敷料及其制备方法 |
US20230218657A1 (en) * | 2020-06-02 | 2023-07-13 | National University Of Singapore | Compositions, their uses in therapy and methods thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4032645A (en) * | 1975-06-19 | 1977-06-28 | G. D. Searle & Co. | Injectable metronidazole composition |
US4267169A (en) * | 1978-07-22 | 1981-05-12 | Toko Yakuhin Kogyo Kabushiki Kaisha | Novel preparation of clotrimazole |
GB8330969D0 (en) * | 1983-11-21 | 1983-12-29 | Wellcome Found | Promoting healing |
DE3346123A1 (de) | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
US4596795A (en) | 1984-04-25 | 1986-06-24 | The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services | Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives |
US4837378A (en) * | 1986-01-15 | 1989-06-06 | Curatek Pharmaceuticals, Inc. | Topical metronidazole formulations and therapeutic uses thereof |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5536743A (en) | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
EP0335545B2 (en) | 1988-03-29 | 1998-09-23 | University Of Florida | Pharmaceutical formulations for parenteral use |
US5997856A (en) | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
TW200402B (es) | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
EP0605428B9 (en) | 1991-06-24 | 2003-01-02 | hCell Technology, Inc. | Hormone-secreting pancreatic cells maintained in long-term culture |
US5747341A (en) | 1991-06-24 | 1998-05-05 | Pacific Biomedical Research, Inc. | Culture media having low osmolarity for establishing and maintaining hormone-secreting cells in long-term culture |
US5472954A (en) | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
US5708023A (en) * | 1994-03-28 | 1998-01-13 | The Trustees Of Columbia University In The City Of New York | Zinc gluconate gel compositions |
FR2722098B1 (fr) * | 1994-07-06 | 1996-08-23 | Cird Galderma | Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine |
US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
ZA987800B (en) * | 1997-08-27 | 1999-06-09 | Hexal Ag | Pharmaceutical composition of meloxicam |
US6017516A (en) * | 1997-10-31 | 2000-01-25 | Lekar Pharma Limited | Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate |
US6183766B1 (en) | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
US6468989B1 (en) * | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
CN1116038C (zh) * | 2000-11-18 | 2003-07-30 | 雷文彬 | 一种治疗痤疮的外用药液 |
-
2001
- 2001-12-24 US US10/033,835 patent/US6881726B2/en not_active Expired - Lifetime
-
2002
- 2002-11-07 MX MXPA04006210A patent/MXPA04006210A/es active IP Right Grant
- 2002-11-07 AT AT02778822T patent/ATE481105T1/de active
- 2002-11-07 WO PCT/US2002/036063 patent/WO2003057135A2/en active Application Filing
- 2002-11-07 AU AU2002340458A patent/AU2002340458B2/en not_active Expired
- 2002-11-07 RU RU2004122696/15A patent/RU2284810C2/ru active
- 2002-11-07 EP EP02778822A patent/EP1467744B1/en not_active Expired - Lifetime
- 2002-11-07 CN CNB028283163A patent/CN100411624C/zh not_active Expired - Fee Related
- 2002-11-07 CA CA2470492A patent/CA2470492C/en not_active Expired - Fee Related
- 2002-11-07 ES ES02778822T patent/ES2352656T3/es not_active Expired - Lifetime
- 2002-11-07 BR BRPI0215331A patent/BRPI0215331B8/pt not_active IP Right Cessation
- 2002-11-07 KR KR1020047010051A patent/KR100718858B1/ko active IP Right Grant
- 2002-11-07 JP JP2003557494A patent/JP4611632B2/ja not_active Expired - Lifetime
- 2002-11-07 EP EP10170958A patent/EP2238980A1/en not_active Ceased
- 2002-11-07 DE DE60237710T patent/DE60237710D1/de not_active Expired - Lifetime
- 2002-11-07 DK DK02778822.3T patent/DK1467744T3/da active
- 2002-11-07 EP EP10170977A patent/EP2241320A1/en not_active Withdrawn
- 2002-11-07 PT PT02778822T patent/PT1467744E/pt unknown
- 2002-12-09 AR ARP020104758A patent/AR037755A1/es not_active Application Discontinuation
-
2004
- 2004-06-25 ZA ZA2004/05059A patent/ZA200405059B/en unknown
-
2005
- 2005-01-18 US US11/037,430 patent/US7348317B2/en not_active Expired - Lifetime
- 2005-04-04 HK HK05102782.3A patent/HK1071514A1/xx not_active IP Right Cessation
-
2006
- 2006-05-11 RU RU2006116252/15A patent/RU2413501C2/ru active
-
2008
- 2008-02-27 US US12/072,578 patent/US20080154030A1/en not_active Abandoned
-
2009
- 2009-10-27 US US12/589,680 patent/US20100048659A1/en not_active Abandoned
-
2010
- 2010-11-11 CY CY20101101017T patent/CY1111095T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04006210A (es) | Composiciones acuosas que contienen metronidazole. | |
ATE267145T1 (de) | Mikronisiertes bariumsulfat | |
MXPA03011006A (es) | Compuestos de cicloalquil urea benzo-fusionados 1,4-disustituidos. | |
HUP0203699A2 (en) | A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties | |
HK1079519A1 (en) | Furyl compounds | |
RS20050769A (en) | Derivatives of 2-acylamino-4- phenylthiazole,preparation method thereof and application of same in therapeutics | |
SG167670A1 (en) | Aminocyclohexyl ether compounds and uses thereof | |
HK1059055A1 (en) | Complex of modafinil and cyclodextrin | |
AU6362100A (en) | Derivatized polyurethane compositions and methods of making | |
MXPA04001686A (es) | Combinaciones de productos activos fungicidas. | |
MXPA05012753A (es) | Composiciones cosmeticas estables que comprenden un agente autobronceador. | |
ATE534384T1 (de) | Verbindungen mit proliferationshemmenden eigenschaften | |
MY133507A (en) | New peroxy-carboxylic acid and aqueous compositions thereof | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
TW200517117A (en) | Stabilized compositions containing an oxygen-labile active agent | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
MXPA03011128A (es) | Composicion de sabor y fragancia. | |
WO1999060859A8 (es) | Composicion desinfectante | |
AU2001251005A1 (en) | Ozonated solutions of tetrasilver tetroxide | |
MXPA04004090A (es) | Compuestos substituidos de 1h-quinolin-2-ona. | |
IL162043A0 (en) | Methods for killing spores | |
AU2001282238A1 (en) | Dihydroporphyrin derivatives and their uses | |
AU2003221507A1 (en) | Composition containing organopolysiloxanes, method for the production thereof and use of the same | |
MXPA03010737A (es) | Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion. | |
EP1436279B8 (en) | Chemical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |